Devasis Chatterjee, Ph.D.
Assistant Professor (Research) of Medicine
The focus of Professor Chatterjee's research is determining mechanisms of resistance to chemotherapeutic agents that lead to metastatic tumor growth in cancer patients and are the primary factors that directly lead to the demise of those afflicted with this disease. His laboratory studies the regulation of two proteins that directly affect tumor cell death (RKIP) and survival and metastasis (STAT3). Professor Chatterjee has found that RKIP is a negative regulator of STAT3, and he is currently validating if RKIP is a candidate to be utilized as the basis for molecular-targeted therapeutic strategy for cancer.
Ph.D. Brown University, 1990
Pharmacology/Molecular Biology
B.S. University of Massachusetts, Amherst, 1982
Zoology/Biochemistry
For more information, please see http://research.brown.edu/myresearch/Devasis_Chatterjee